Specific Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 63
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.9M
Latest Deal Amount
  • Investors
  • 5

Specific General Information


Developer of a small molecule sensor (SMS) array designed to determine the effective antibiotic. The company's product includes an instrument and assay which responds to the metabolic byproducts produced by microorganisms to detect growth, assess antibiotic efficacy and determine microorganism ID, enabling doctors to detect low (part per billion) concentrations of volatile organic compounds (VOCs) in very complex mixtures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Electronic Equipment and Instruments
Other Devices and Supplies
Primary Office
  • 130 Baytech Drive
  • San Jose, CA 95134
  • United States
+1 (650) 000-0000

Specific Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Specific Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Jun-2020 $2.9M 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 06-Sep-2019 000.00 000.00 000.00 Completed Generating Revenue
3. Grant 07-Aug-2019 00.00 Completed Generating Revenue
2. Grant 01-Jan-2017 $3.99M Completed Generating Revenue
1. Grant 01-Jan-2013 $145K Completed Generating Revenue
To view Specific’s complete valuation and funding history, request access »

Specific Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 000
To view Specific’s complete cap table history, request access »

Specific Executive Team (4)

Name Title Board Seat Contact Info
Paul Rhodes Ph.D Chief Executive Officer
Ray Martino Co-Founder and Chief Operating Officer
Anthony Bazarko Chief Commercial Officer
Kenneth Suslick Ph.D Member of US Scientific Advisory Board
To view Specific’s complete executive team members history, request access »

Specific Board Members (1)

Name Representing Role Since
Paul Grossman Ph.D Telegraph Hill Partners Board Member 000 0000
To view Specific’s complete board members history, request access »

Specific Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Specific Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
BioMérieux Corporation Minority 000 0000 000000 0
Telegraph Hill Partners Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Specific’s complete investors history, request access »